While Bayer AG is considering how to respond to Monsanto Co.’s rejection of its $62 billion takeover bid, investors and analysts are questioning whether the German pharmaceutical and chemicals giant can up its offer.
WSJ.com: US Business, Wall Street Journal: Business
Wed, 05/25/2016 - 10:21am